Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Fennec Pharmaceuticals Inc. (FENC)

April 8, 2026 7:15 AM EDT Send to a Friend
H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $13.00 price target on Fennec Pharmaceuticals Inc. (NASDAQ: FENC).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login